Literature DB >> 22302484

Nuclisome--targeting the tumor cell nucleus.

Lars Gedda1, Katarina Edwards.   

Abstract

The Nuclisome concept builds on a novel two-step targeting strategy with the aim to deliver short-range Auger-electron-emitting radionuclides to nuclear DNA of tumor cells. The concept is based on the use of Nuclisome-particles, i.e., tumor-targeted PEG-stabilized liposomes loaded with a unique DNA-intercalating compound that enables specific and effective delivery of radionuclides to DNA. The specific and potent two-step targeting leads to eradication of tumor cells while toxicity to normal organs is reduced to a minimum. Results of in vitro and in vivo studies point towards the Nuclisome concept as a promising strategy for the treatment of small tumor masses and, in particular, for the elimination of spread single cells and micrometastases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302484     DOI: 10.1007/s13277-012-0341-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

1.  Ellipticine-aimed polymer-conjugated auger electron emitter: multistage organelle targeting approach.

Authors:  Ondrej Sedlacek; Martin Hruby; Martin Studenovsky; Jan Kucka; David Vetvicka; Lubomir Kovar; Blanka Rihova; Karel Ulbrich
Journal:  Bioconjug Chem       Date:  2011-05-04       Impact factor: 4.774

2.  Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.

Authors:  Paul Chen; Judy Wang; Kristin Hope; Liqing Jin; John Dick; Ross Cameron; Joseph Brandwein; Mark Minden; Raymond M Reilly
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

3.  Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient.

Authors:  L D Mayer; M B Bally; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1986-05-09

Review 4.  Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives.

Authors:  J P Spano; R Fagard; J-C Soria; O Rixe; D Khayat; G Milano
Journal:  Ann Oncol       Date:  2005-02       Impact factor: 32.976

5.  Nuclisome: a novel concept for radionuclide therapy using targeting liposomes.

Authors:  Amelie Fondell; Katarina Edwards; Ludger M Ickenstein; Stefan Sjöberg; Jörgen Carlsson; Lars Gedda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

Review 6.  The EGF receptor family as targets for cancer therapy.

Authors:  J Mendelsohn; J Baselga
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

7.  Cytotoxicity and subcellular localization of boronated phenanthridinium analogues.

Authors:  L Gedda; M Silvander; S Sjöberg; W Tjarks; J Carlsson
Journal:  Anticancer Drug Des       Date:  1997-12

8.  Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.

Authors:  Senait Ghirmai; Eskender Mume; Vladimir Tolmachev; Stefan Sjöberg
Journal:  Carbohydr Res       Date:  2005-01-17       Impact factor: 2.104

9.  Experimental radionuclide therapy of HER2-expressing xenografts using two-step targeting nuclisome particles.

Authors:  Lars Gedda; Amelie Fondell; Hans Lundqvist; John W Park; Katarina Edwards
Journal:  J Nucl Med       Date:  2012-02-08       Impact factor: 10.057

10.  Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies.

Authors:  Qichun Wei; Erika Bohl Kullberg; Lars Gedda
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

View more
  1 in total

Review 1.  Current trends in the use of liposomes for tumor targeting.

Authors:  Pranali P Deshpande; Swati Biswas; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.